Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06038_nanopub.RAhNt9DxeG6fkUGEpXA0lxwepW8ZoPl-5R8vV5l44vxhs#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB06038 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06038 label "ITMN-191 [drugbank:DB06038]" assertion.
- drugbank:DB06038 seeAlso DB06038 assertion.
- drugbank:DB06038 description "ITMN 191 is a novel oral HCV NS3/4A protease inhibitor being developed by InterMune. ITMN 191 to be metabolized by multiple isoforms of the cytochrome P450 (CYP) enzyme system. ITMN 191 did not inhibit isoforms 1A2, 2C19, 2C9, or 2D6, but did reduce activity of isofom 3A4 by about one-third; this has implications for drug interactions." assertion.
- drugbank:DB06038 identifier "drugbank:DB06038" assertion.
- drugbank:DB06038 title "ITMN-191" assertion.
- drugbank:DB06038 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB06038 drugbank_vocabulary:drugbank-id "DB06038" assertion.
- drugbank:DB06038 bio2rdf_vocabulary:x-identifiers.org DB06038 assertion.
- drugbank:DB06038 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06038" assertion.
- drugbank:DB06038 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06038 bio2rdf_vocabulary:identifier "DB06038" assertion.